PPROM Registry (Preterm Premature Rupture of Membranes)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age14-55
SponsorAmerican Alliance for pProm Support

About this trial

Preterm Premature Rupture of Membranes (PPROM) before 37 weeks of pregnancy is responsible for 40% of preterm births in the United States. The PPROM Registry aims to identify possible causes of PPROM, evaluate trends in expectant management, measure maternal and fetal care, and to review short term and long term outcomes of affected pregnancies and births.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Women diagnosed with Preterm Premature Rupture of Membranes (PPROM) prior to 37 weeks of pregnancy

Disqualifiers

Those without a clinical diagnosis or confirmation of PPROM in pregnancy

Diagnosis of PROM beyond 37 weeks of pregnancy

Trial population

Women diagnosed with Preterm Premature Rupture of Membranes (PPROM) prior to 37 weeks of pregnancy

Trial design

Design model

Ecologic or community

Time perspective

Other

Treatments tested in this trial

  • There is no intervention associated with this study.

    Other intervention

    There is no intervention associated with this study.

Treatment groups

3,000 Participants
are divided into 1 treatment group
Group A: PPROM (Preterm Premature Rupture of Membranes)1 intervention

Trial outcomes

Primary outcomes

1

Early Neonatal Mortality Rate

Time frame
28 days post delivery

Secondary outcomes

1

Stillbirth / Perinatal Mortality Rate

Time frame
Upon delivery

Other outcomes

1

Review of Socio-Economic Factors in pProm

Time frame
Single assessment (observational) at conclusion of pregnancy +30 days, monitored for up to 100 months

Sponsors and contacts

Click on the lead sponsor to view all of their trials.